timolol has been researched along with nipradilol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koibuchi, H; Koseki, Y; Nagataki, S; Yamakawa, R | 1 |
| Araie, M; Kanno, M; Sawanobori, K; Tomita, K | 1 |
| Araie, M; Kanno, M; Koibuchi, H; Masuda, K | 1 |
| Araie, M; Koide, T; Mizuno, K; Yoshimura, M | 1 |
| Aizawa, T; Hashizume, K; Ikeo, S; Komatsu, M; Nakajima, K; Nishimura, Y; Yamauchi, K | 1 |
| Iizuka, Y; Kashiwagi, K; Tsukahara, S | 1 |
| Hirano, S; Nishida, T; Sagara, T; Seki, K; Suzuki, K | 1 |
| Araie, M; Azuma, I; Kanno, M; Kitazawa, Y; Masuda, K; Ogawa, N; Ohdo, S; Shiose, Y; Takase, M | 2 |
| Izumi, H; Kohno, K; Kubota, T; Miyamoto, N; Miyamoto, R; Sasaguri, Y; Tawara, A | 1 |
| Araie, M; Kitazawa, Y; Ohashi, Y; Shirato, S; Yamazaki, Y | 1 |
| Araie, M; Kitazawa, Y; Matsumoto, C; Ohashi, Y; Shirato, S; Yamazaki, Y | 1 |
6 trial(s) available for timolol and nipradilol
| Article | Year |
|---|---|
[Effect of nipradilol on aqueous flow in glaucoma patients treated with timolol].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aqueous Humor; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Propanolamines; Timolol | 1997 |
Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aqueous Humor; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Propanolamines; Timolol | 2000 |
Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Aged; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Propanolamines; Timolol; Vasodilator Agents | 2006 |
Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Part 2.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Double-Blind Method; Electrocardiography; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Propanolamines; Timolol | 2006 |
Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study.
Topics: Administration, Topical; Adult; Antihypertensive Agents; Disease Progression; Double-Blind Method; Female; Humans; Intraocular Pressure; Low Tension Glaucoma; Male; Middle Aged; Ophthalmic Solutions; Propanolamines; Timolol; Treatment Outcome; Vision Disorders; Visual Field Tests; Visual Fields | 2010 |
Risk factors for progression of normal-tension glaucoma under β-blocker monotherapy.
Topics: Adrenergic beta-Antagonists; Disease Progression; Double-Blind Method; Female; Humans; Intraocular Pressure; Low Tension Glaucoma; Male; Middle Aged; Myopia; Ophthalmic Solutions; Prognosis; Propanolamines; Prospective Studies; Risk Factors; Timolol; Tonometry, Ocular; Vision Disorders; Visual Fields | 2012 |
6 other study(ies) available for timolol and nipradilol
| Article | Year |
|---|---|
Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aqueous Humor; Blood Circulation; Blood Flow Velocity; Blood-Aqueous Barrier; Capillary Permeability; Dose-Response Relationship, Drug; Fluorophotometry; Fundus Oculi; Intraocular Pressure; Nitroglycerin; Optic Disk; Propanolamines; Rabbits; Sclera; Timolol; Uvea; Vasodilator Agents | 1998 |
Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood-Retinal Barrier; Cell Count; Dose-Response Relationship, Drug; Drug Combinations; Male; N-Methylaspartate; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Propanolamines; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Retina; Retinal Artery; Timolol; Vasoconstriction | 2001 |
Effects of nipradilol, a nitric oxide-releasing beta-adrenoceptor blocking agent, on phosphoenolpyruvate carboxykinase gene transcription in a rat hepatoma cell line.
Topics: Adrenergic beta-Antagonists; Animals; Carcinoma, Hepatocellular; Dexamethasone; Gene Expression Regulation, Enzymologic; Hepatocytes; Insulin; Methylene Blue; Nitric Oxide; Phosphoenolpyruvate Carboxykinase (ATP); Propanolamines; Rats; Timolol; Transcription, Genetic; Tumor Cells, Cultured | 2001 |
Neuroprotective effects of nipradilol on purified cultured retinal ganglion cells.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Antihypertensive Agents; Cell Separation; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Cyclic N-Oxides; Dose-Response Relationship, Drug; Flow Cytometry; Imidazoles; Neuroprotective Agents; Nitric Oxide; Propanolamines; Quinazolines; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Timolol | 2002 |
Inhibitory effects of anti-glaucoma drugs on corneal epithelial migration in a rabbit organ culture system.
Topics: Animals; Antihypertensive Agents; Cell Movement; Dose-Response Relationship, Drug; Epithelium, Corneal; Latanoprost; Organ Culture Techniques; Propanolamines; Prostaglandins F, Synthetic; Rabbits; Timolol; Wound Healing | 2004 |
Nipradilol and timolol induce Foxo3a and peroxiredoxin 2 expression and protect trabecular meshwork cells from oxidative stress.
Topics: Antihypertensive Agents; Blotting, Western; Cell Survival; Cells, Cultured; Cytoprotection; Electrophoresis, Polyacrylamide Gel; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Gene Silencing; Humans; Hydrogen Peroxide; Oxidative Stress; Peroxiredoxins; Plasmids; Propanolamines; RNA, Small Interfering; Timolol; Trabecular Meshwork | 2009 |